Literature DB >> 29470978

Contractile responses to endothelin-1 are regulated by PKC phosphorylation of cardiac myosin binding protein-C in rat ventricular myocytes.

Ioannis Smyrnias1, Normann Goodwin1, Dagmar Wachten1, Jonas Skogestad2, Jan Magnus Aronsen3, Emma L Robinson4, Kateryna Demydenko4, Anne Segonds-Pichon1, David Oxley1, Sakthivel Sadayappan5, Karin Sipido4, Martin D Bootman1, H Llewelyn Roderick6.   

Abstract

The shortening of sarcomeres that co-ordinates the pump function of the heart is stimulated by electrically-mediated increases in [Ca2+]. This process of excitation-contraction coupling (ECC) is subject to modulation by neurohormonal mediators that tune the output of the heart to meet the needs of the organism. Endothelin-1 (ET-1) is a potent modulator of cardiac function with effects on contraction amplitude, chronotropy and automaticity. The actions of ET-1 are evident during normal adaptive physiological responses and increased under pathophysiological conditions, such as following myocardial infarction and during heart failure, where ET-1 levels are elevated. In myocytes, ET-1 acts through ETA- or ETB-G protein-coupled receptors (GPCRs). Although well studied in atrial myocytes, the influence and mechanisms of action of ET-1 upon ECC in ventricular myocytes are not fully resolved. We show in rat ventricular myocytes that ET-1 elicits a biphasic effect on fractional shortening (initial transient negative and sustained positive inotropy) and increases the peak amplitude of systolic Ca2+ transients in adult rat ventricular myocytes. The negative inotropic phase was ETB receptor-dependent, whereas the positive inotropic response and increase in peak amplitude of systolic Ca2+ transients required ETA receptor engagement. Both effects of ET-1 required phospholipase C (PLC)-activity, although distinct signalling pathways downstream of PLC elicited the effects of each ET receptor. The negative inotropic response involved inositol 1,4,5-trisphosphate (InsP3) signalling and protein kinase C epsilon (PKCε). The positive inotropic action and the enhancement in Ca2+ transient amplitude induced by ET-1 were independent of InsP3 signalling, but suppressed by PKCε. Serine 302 in cardiac myosin binding protein-C was identified as a PKCε substrate that when phosphorylated contributed to the suppression of contraction and Ca2+ transients by PKCε following ET-1 stimulation. Thus, our data provide a new role and mechanism of action for InsP3 and PKCε in mediating the negative inotropic response and in restraining the positive inotropy and enhancement in Ca2+ transients following ET-1 stimulation.
Copyright © 2018 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Cardiac myocyte; ECC; Endothelin; InsP(3); PKC

Mesh:

Substances:

Year:  2018        PMID: 29470978     DOI: 10.1016/j.yjmcc.2018.02.012

Source DB:  PubMed          Journal:  J Mol Cell Cardiol        ISSN: 0022-2828            Impact factor:   5.000


  11 in total

1.  Ca2+ Release via IP3 Receptors Shapes the Cardiac Ca2+ Transient for Hypertrophic Signaling.

Authors:  Hilary Hunt; Agnė Tilūnaitė; Greg Bass; Christian Soeller; H Llewelyn Roderick; Vijay Rajagopal; Edmund J Crampin
Journal:  Biophys J       Date:  2020-08-13       Impact factor: 4.033

2.  Cardiac myosin binding protein-C phosphorylation regulates the super-relaxed state of myosin.

Authors:  James W McNamara; Rohit R Singh; Sakthivel Sadayappan
Journal:  Proc Natl Acad Sci U S A       Date:  2019-05-29       Impact factor: 11.205

3.  DREADD technology reveals major impact of Gq signalling on cardiac electrophysiology.

Authors:  Elisabeth Kaiser; Qinghai Tian; Michael Wagner; Monika Barth; Wenying Xian; Laura Schröder; Sandra Ruppenthal; Lars Kaestner; Ulrich Boehm; Philipp Wartenberg; Huiyan Lu; Sara M McMillin; Derek B J Bone; Jürgen Wess; Peter Lipp
Journal:  Cardiovasc Res       Date:  2019-05-01       Impact factor: 10.787

4.  Endothelin-1, cardiac morphology, and heart failure: the MESA angiogenesis study.

Authors:  Peter J Leary; Nancy S Jenny; David A Bluemke; Steven M Kawut; Richard A Kronmal; Joao A Lima; Bradley A Maron; David D Ralph; Samuel G Rayner; John J Ryan; Zachary L Steinberg; Karen D Hinckley Stukovsky; Ryan J Tedford
Journal:  J Heart Lung Transplant       Date:  2019-08-10       Impact factor: 10.247

5.  Obstruction of ventricular Ca2+ -dependent arrhythmogenicity by inositol 1,4,5-trisphosphate-triggered sarcoplasmic reticulum Ca2+ release.

Authors:  Joaquim Blanch I Salvador; Marcel Egger
Journal:  J Physiol       Date:  2018-08-07       Impact factor: 5.182

Review 6.  Calcium Signaling in Cardiomyocyte Function.

Authors:  Guillaume Gilbert; Kateryna Demydenko; Eef Dries; Rosa Doñate Puertas; Xin Jin; Karin Sipido; H Llewelyn Roderick
Journal:  Cold Spring Harb Perspect Biol       Date:  2020-03-02       Impact factor: 10.005

Review 7.  PKC and PKN in heart disease.

Authors:  Valeria Marrocco; Julius Bogomolovas; Elisabeth Ehler; Cristobal G Dos Remedios; Jiayu Yu; Chen Gao; Stephan Lange
Journal:  J Mol Cell Cardiol       Date:  2019-02-08       Impact factor: 5.000

8.  The cross-talk between PARylation and SUMOylation in C/EBPβ at K134 site participates in pathological cardiac hypertrophy.

Authors:  Luping Wang; Panxia Wang; Suowen Xu; Zhuoming Li; Dayue Darrel Duan; Jiantao Ye; Jingyan Li; Yanqing Ding; Wenqing Zhang; Jing Lu; Peiqing Liu
Journal:  Int J Biol Sci       Date:  2022-01-01       Impact factor: 6.580

9.  FBXL10 regulates cardiac dysfunction in diabetic cardiomyopathy via the PKC β2 pathway.

Authors:  Leilei Yin; Yingying Fang; Tao Song; Dan Lv; Zheng Wang; Li Zhu; Zihui Zhao; Xinhua Yin
Journal:  J Cell Mol Med       Date:  2019-01-31       Impact factor: 5.310

10.  Contributions of Sodium-Hydrogen Exchanger 1 and Mitogen-Activated Protein Kinases to Enhanced Retinal Venular Constriction to Endothelin-1 in Diabetes.

Authors:  Yen-Lin Chen; Yi Ren; Robert H Rosa; Lih Kuo; Travis W Hein
Journal:  Diabetes       Date:  2021-08-05       Impact factor: 9.337

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.